Trinh L A, Ferrini R, Cobb B S, Weinmann A S, Hahm K, Ernst P, Garraway I P, Merkenschlager M, Smale S T
Howard Hughes Medical Institute, Department of Microbiology, Immunology, and Molecular Genetics, and Molecular Biology Institute, University of California, Los Angeles, California 90095-1662, USA.
Genes Dev. 2001 Jul 15;15(14):1817-32. doi: 10.1101/gad.905601.
Ikaros is a unique regulator of lymphopoiesis that associates with pericentromeric heterochromatin and has been implicated in heritable gene inactivation. Binding and competition experiments demonstrate that Ikaros dimers compete with an Ets activator for occupancy of the lymphocyte-specific TdT promoter. Mutations that selectively disrupt Ikaros binding to an integrated TdT promoter had no effect on promoter function in a CD4(+)CD8(+) thymocyte line. However, these mutations abolished down-regulation on differentiation, providing evidence that Ikaros plays a direct role in repression. Reduced access to restriction enzyme cleavage suggested that chromatin alterations accompany down-regulation. The Ikaros-dependent down-regulation event and the observed chromatin alterations appear to precede pericentromeric repositioning. Current models propose that the functions of Ikaros should be disrupted by a small isoform that retains the dimerization domain and lacks the DNA-binding domain. Surprisingly, in the CD4(+)CD8(+) thymocyte line, overexpression of a small Ikaros isoform had no effect on differentiation or on the pericentromeric targeting and DNA-binding properties of Ikaros. Rather, the small isoform assembled into multimeric complexes with DNA-bound Ikaros at the pericentromeric foci. The capacity for in vivo multimer formation suggests that interactions between Ikaros dimers bound to the TdT promoter and those bound to pericentromeric repeat sequences may contribute to the pericentromeric repositioning of the inactive gene.
Ikaro是淋巴细胞生成的一种独特调节因子,它与着丝粒周围异染色质相关联,并参与遗传性基因失活。结合和竞争实验表明,Ikaro二聚体与一种Ets激活因子竞争淋巴细胞特异性末端脱氧核苷酸转移酶(TdT)启动子的占据。选择性破坏Ikaro与整合的TdT启动子结合的突变对CD4(+)CD8(+)胸腺细胞系中的启动子功能没有影响。然而,这些突变消除了分化过程中的下调,这表明Ikaro在抑制中起直接作用。限制酶切割的可及性降低表明染色质改变伴随着下调。Ikaro依赖的下调事件和观察到的染色质改变似乎先于着丝粒周围重新定位。目前的模型提出,Ikaro的功能应该被一种保留二聚化结构域且缺乏DNA结合结构域的小异构体破坏。令人惊讶的是,在CD4(+)CD8(+)胸腺细胞系中,小Ikaro异构体的过表达对分化或Ikaro的着丝粒靶向和DNA结合特性没有影响。相反,小异构体在着丝粒焦点处与结合DNA的Ikaro组装成多聚体复合物。体内形成多聚体 的能力表明,与TdT启动子结合的Ikaro二聚体和与着丝粒重复序列结合的二聚体之间的相互作用可能有助于无活性基因的着丝粒重新定位。